X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5573) 5573
Book Chapter (14) 14
Book / eBook (6) 6
Dissertation (4) 4
Book Review (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (4484) 4484
male (2401) 2401
rats (2151) 2151
adenosine - pharmacology (1743) 1743
adenosine (1741) 1741
humans (1726) 1726
index medicus (1472) 1472
purinergic p1 receptor antagonists (1438) 1438
receptors, purinergic p1 - metabolism (1255) 1255
adenosine - analogs & derivatives (1204) 1204
neurosciences (1101) 1101
purinergic p1 receptor agonists (1020) 1020
pharmacology & pharmacy (1010) 1010
receptors, purinergic p1 - physiology (982) 982
mice (889) 889
in vitro techniques (839) 839
receptors, purinergic p1 - drug effects (836) 836
female (799) 799
dose-response relationship, drug (784) 784
rats, sprague-dawley (773) 773
rats, wistar (729) 729
xanthines - pharmacology (693) 693
receptors (688) 688
adenosine - metabolism (670) 670
adenosine triphosphate - pharmacology (630) 630
atp (627) 627
theophylline - pharmacology (579) 579
physiology (568) 568
cells, cultured (563) 563
adenosine receptors (530) 530
cell biology (474) 474
biochemistry & molecular biology (466) 466
receptor (425) 425
theophylline - analogs & derivatives (421) 421
activation (411) 411
adenosine triphosphate - metabolism (378) 378
calcium - metabolism (378) 378
phenethylamines - pharmacology (369) 369
signal transduction (363) 363
adenosine - physiology (350) 350
rat (344) 344
cells (335) 335
physiological aspects (335) 335
release (332) 332
receptor, adenosine a2a (310) 310
enzyme inhibitors - pharmacology (308) 308
inflammation (305) 305
time factors (304) 304
biomedicine (302) 302
receptors, purinergic p1 - genetics (302) 302
caffeine - pharmacology (298) 298
brain (292) 292
adenosine receptor (291) 291
adenosine triphosphate - analogs & derivatives (286) 286
expression (286) 286
cyclic amp - metabolism (276) 276
receptors, purinergic p2 - metabolism (275) 275
signal transduction - drug effects (275) 275
inhibition (271) 271
neurons (264) 264
a receptors (263) 263
caffeine (262) 262
guinea pigs (261) 261
cardiac & cardiovascular systems (260) 260
research (255) 255
adenosine a (254) 254
neurons - drug effects (252) 252
vasodilator agents - pharmacology (250) 250
extracellular atp (249) 249
disease models, animal (241) 241
mice, inbred c57bl (237) 237
electric stimulation (233) 233
signal transduction - physiology (233) 233
rabbits (232) 232
triazoles - pharmacology (230) 230
blood pressure - drug effects (223) 223
ischemia (220) 220
cell line (218) 218
a receptor (215) 215
analysis (215) 215
pharmacology/toxicology (212) 212
nucleotides (208) 208
heart rate - drug effects (202) 202
hippocampus - drug effects (198) 198
rodents (198) 198
central-nervous-system (197) 197
neurons - metabolism (193) 193
peripheral vascular disease (191) 191
myocardium - metabolism (187) 187
brain - metabolism (186) 186
vasodilation - drug effects (186) 186
purinergic receptors (185) 185
research article (185) 185
purinoceptors (184) 184
apoptosis (183) 183
proteins (182) 182
nitric-oxide (180) 180
middle aged (179) 179
ligands (178) 178
purinergic p2 receptor antagonists (176) 176
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5554) 5554
Japanese (53) 53
Russian (18) 18
Chinese (8) 8
Spanish (6) 6
German (5) 5
Polish (4) 4
Swedish (3) 3
French (2) 2
Hungarian (2) 2
Czech (1) 1
Danish (1) 1
Finnish (1) 1
Italian (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Purinergic Signalling, ISSN 1573-9538, 9/2012, Volume 8, Issue 3, pp. 419 - 436
...Purinergic Signalling (2012) 8:419 – 436 DOI 10.1007/s11302-012-9294-7 ORIGINAL ARTICLE G protein-coupled adenosine (P1) and P2Y receptors: ligand design... 
Clinical trials, nucleosides | Neurosciences | Adenosine receptors | Human Physiology | P2Y receptors | Antagonists | Nucleotides | Biomedicine general | Biomedicine | GPCR structure | Cancer Research | Agonists | Pharmacology/Toxicology | PHYLOGENETIC ANALYSIS | A(2B) ADENOSINE | ANTAGONIST RECOGNITION | SITE-DIRECTED MUTAGENESIS | MUTATIONAL ANALYSIS | NEUROSCIENCES | NUCLEOTIDE RECEPTORS | INTERNATIONAL UNION | SUBTYPE SELECTIVITY | MOLECULAR RECOGNITION | PURINERGIC RECEPTORS | Receptors, G-Protein-Coupled - metabolism | Humans | Purinergic P2Y Receptor Agonists - therapeutic use | Purinergic P1 Receptor Agonists - therapeutic use | Purinergic P1 Receptor Antagonists - pharmacology | Receptors, Purinergic P1 - chemistry | Receptors, Purinergic P2 - chemistry | Drug Design | Receptors, G-Protein-Coupled - drug effects | Purinergic P2Y Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Antagonists - pharmacology | Purinergic P1 Receptor Agonists - chemistry | Purinergic P1 Receptor Agonists - pharmacology | Purinergic P1 Receptor Antagonists - therapeutic use | Purinergic P2Y Receptor Agonists - chemistry | Clinical Trials as Topic | Receptors, Purinergic P2 - drug effects | Purinergic P2Y Receptor Agonists - pharmacology | Animals | Purinergic P2Y Receptor Antagonists - chemistry | Receptors, Purinergic P2 - metabolism | Ligands | Receptors, Purinergic P1 - metabolism | Receptors, Purinergic P1 - drug effects | Receptors, G-Protein-Coupled - chemistry | Purinergic P1 Receptor Antagonists - chemistry | Glaucoma | Heart | Adenosine | Parkinson's disease | Psoriasis | Cystic fibrosis | Rheumatoid factor | Hepatitis | Alkaloids | Pyrimidines | Heterocyclic compounds | Emissions (Pollution) | Rheumatoid arthritis | Respiratory tract diseases | Eye diseases | G proteins | Diabetes | Ophthalmology | Kidney diseases | Hepatitis C | DNA-ligand interactions | Arrhythmia | Clinical trials | Ionizing radiation | Reperfusion | Ischemia | pyrimidines | Injuries | Movement disorders | Neurodegenerative diseases | Diabetes mellitus | Lung diseases | Pharmacology | Thrombosis | imaging | Stress | Purine P2Y receptors | purines | Hypoxia | Receptor mechanisms | ATP | Cancer | Pharmaceuticals | Original
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2005, Volume 310, Issue 5745, pp. 113 - 116
To investigate the role of astrocytes in regulating synaptic transmission, we generated inducible transgenic mice that express a dominant-negative SNARE domain... 
Neuroscience | Receptors | Transmitters | Astrocytes | Synaptic transmission | Neurons | Long term potentiation | Reports | Mice | Behavioral neuroscience | Synapses | NERVOUS-SYSTEM | TRANSMISSION | ADENINE-NUCLEOTIDES | GLUTAMATE | MULTIDISCIPLINARY SCIENCES | CALCIUM WAVES | ADENOSINE | RAT HIPPOCAMPUS | RELEASE | ATP | CULTURED HIPPOCAMPAL-NEURONS | Purinergic P1 Receptor Antagonists | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Receptors, N-Methyl-D-Aspartate - metabolism | Neuronal Plasticity - drug effects | Hippocampus - drug effects | Xanthines - pharmacology | Adenosine Triphosphate - pharmacology | Long-Term Potentiation - drug effects | Excitatory Postsynaptic Potentials | Adenosine Triphosphate - metabolism | Synaptic Transmission - drug effects | Astrocytes - drug effects | Synapses - physiology | Adenosine A1 Receptor Antagonists | Cells, Cultured | Purinergic P2 Receptor Antagonists | Mice, Transgenic | Receptor, Adenosine A1 - metabolism | Adenosine Triphosphate - analogs & derivatives | Adenosine Triphosphatases - antagonists & inhibitors | Astrocytes - physiology | Animals | Receptors, Purinergic P2 - metabolism | Adenosine - metabolism | Receptors, Purinergic P1 - metabolism | Hippocampus - physiology | In Vitro Techniques | Neural transmission | Neuroglia | Research | Neurology | Adenosine
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 02/2016, Volume 99, Issue 2, pp. 289 - 299
.... Purinergic signaling regulates both M1 and M2 macrophage function at different levels by controlling the secretion of cytokines, phagocytosis, and the production of reactive oxygen species... 
Adenosine | Receptors | Extracellular ATP | Purinergic receptors | Ym1 | GAMMA | purinergic receptors | PROTEIN | RELEASE | IMMUNOLOGY | MURINE | CELL BIOLOGY | adenosine | NUCLEOTIDE RECEPTORS | MONOCYTE | adenosine receptors | HEMATOLOGY | EXPRESSION | POLARIZATION | extracellular ATP | beta-N-Acetylhexosaminidases - pharmacology | Inflammation - pathology | Receptors, Purinergic P2X7 - drug effects | Adenine Nucleotides - pharmacology | Lectins - biosynthesis | Receptors, Purinergic P2X7 - genetics | Interleukin-4 - pharmacology | Purinergic P2 Receptor Antagonists - pharmacology | Purinergic P2 Receptor Agonists - pharmacology | beta-N-Acetylhexosaminidases - genetics | Myelopoiesis - drug effects | Macrophages - classification | Specific Pathogen-Free Organisms | Gene Expression Regulation - immunology | Mice, Inbred C57BL | Purinergic P1 Receptor Agonists - pharmacology | Cells, Cultured | Lectins - pharmacology | Receptors, Purinergic P1 - physiology | Receptors, Purinergic P2 - physiology | Adenine - pharmacology | Inflammation - immunology | Macrophages - cytology | Recombinant Proteins - pharmacology | beta-N-Acetylhexosaminidases - biosynthesis | Cell Division - drug effects | Mice, Knockout | Gene Expression Regulation - drug effects | Receptors, Purinergic P2X7 - deficiency | Phenotype | Animals | Signal Transduction - drug effects | Lipopolysaccharides - pharmacology | Lectins - genetics | Macrophages - drug effects | Receptors, Purinergic P2X7 - biosynthesis | Mice | Cell Cycle - drug effects | Macrophage Activation - drug effects | Interferon-gamma - pharmacology
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2011, Volume 26, Issue 9, pp. 2112 - 2124
Journal Article
Journal Article